This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Silva, J. Articles by Bonilla, F. Search for Related Content PubMed PubMed Citation Articles by Silva, J. Articles by Bonilla, F.

Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast Carcinomas

Authors' Affiliations: Departments of ¹ Medical Oncology and ² Pathology, Hospital Universitario Puerta de Hierro, Madrid, Spain and ³ Department of Pathology, Hospital Virgen de la Salud, Toledo, Spain

Requests for reprints: Félix Bonilla, Department of Medical Oncology, Hospital Universitario Puerta de Hierro, C/ San Martín de Porres, 4, E-28035 Madrid, Spain. Phone: 34-91-386-6527; Fax: 34-91-373-7667; E-mail: felixbv{at}stnet.es.

Purpose: Deregulation of mammalian Polycomb group (PcG) members may contribute to human carcinogenesis. p16INK4a and p14ARF tumor suppressors, human telomerase reverse transcriptase (h-TERT), and oncoprotein c-Myc have been implicated in the regulation of the cell cycle and proliferation mediated by PcG proteins, mainly Bmi-1, in mice and in cell culture experiments. Here, we examine whether these in vitro findings can be extrapolated to the in vivo situation.

Experimental Design: We measure the expression of PcG members Bmi-1, Mel-18, and Hpc-2 and their potential targets by reverse transcription-PCR, immunostaining, and Western blotting in a series of 134 breast carcinomas and correlate the data with several clinical-pathologic variables of the tumors.

Results: Expression of PcG genes was variably detected, but overexpression of Bmi-1 was the most frequent PcG alteration observed. In addition, statistical direct correlation in expression level of the three PcG members was detected. A correlation between c-Myc and Bmi-1 expression levels was observed; however, there was no correlation between expression of Bmi-1 and p16INK4a, p14ARF, or h-TERT. However, expression of the other PcG members Mel-18 and Hpc-2 correlated with the cell cycle regulators. Moreover, PcG mRNA–altered expression correlated significantly with certain clinical-pathologic variables associated with poor prognosis.

Conclusions: Our data suggest that the oncogenic role of Bmi-1 in human primary breast carcinomas is not determined by its capacity to inhibit INK4a/ARF proteins or to induce telomerase activity.

This article has been cited by other articles:

				D. Wiederschain, L. Chen, B. Johnson, K. Bettano, D. Jackson, J. Taraszka, Y. K. Wang, M. D. Jones, M. Morrissey, J. Deeds, et al. Contribution of Polycomb Homologues Bmi-1 and Mel-18 to Medulloblastoma Pathogenesis Mol. Cell. Biol., July 1, 2007; 27(13): 4968 - 4979. [Abstract] [Full Text] [PDF]

				W.-J. Guo, M.-S. Zeng, A. Yadav, L.-B. Song, B.-H. Guo, V. Band, and G. P. Dimri Mel-18 Acts as a Tumor Suppressor by Repressing Bmi-1 Expression and Down-regulating Akt Activity in Breast Cancer Cells Cancer Res., June 1, 2007; 67(11): 5083 - 5089. [Abstract] [Full Text] [PDF]